Iraqi Judoka Fails First Doping Test of Paris 2024 Olympics
The International Testing Agency (ITA) has confirmed the first positive doping test of the 2024 Paris Olympics, involving Iraqi judoka Sajjad Sehen. The athlete tested positive for banned anabolic steroids methandienone and boldenone during an out-of-competition anti-doping control in Paris.
The ITA revealed that Sehen’s sample “returned an adverse analytical finding for the non-specified prohibited substances metandienone and boldenone.” Both drugs are prohibited by the World Anti-Doping Agency (WADA). The sample was collected on Tuesday and the result was reported by the WADA-accredited laboratory of Paris on Thursday.
The 28-year-old Sehen, a first-time Olympian, was scheduled to compete in the men’s 81-kilogram class next week. However, he has been provisionally suspended until the resolution of the matter.
“This means that the athlete is prevented from competing, training, coaching, or participating in any activity during the Olympic Games Paris 2024,” the ITA statement said.
Herda Raouf, the manager of Iraq’s delegation, stated that Sehen and his coach will be questioned by doping chiefs on Saturday. Raouf suggested that Sehen may have taken medication due to a recent surgical operation.
Sehen has the right to challenge his provisional suspension at the Court of Arbitration for Sport and can also request an analysis of the B sample. The ITA manages an independent anti-doping program for the Paris Olympics on behalf of the International Olympic Committee.
This incident highlights the importance of anti-doping measures in ensuring fair play and protecting the integrity of the Olympic Games. The ITA’s swift action in detecting and reporting the positive test sends a strong message that doping will not be tolerated.
